NFKB1 and hepatocellular carcinoma: Our previous studies presented that inhibition of ERK/NF‐κB signaling‐mediated proliferation, anti‐apoptotic, and invasion‐associated proteins expression was associated with both sorafenib and regorafenib‐inhibited progression of HCC.36, 37